These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 19706293)

  • 21. Endothelial protein C receptor plasma levels increase in chronic liver disease, while thrombomodulin plasma levels increase only in hepatocellular carcinoma.
    Biguzzi E; Franchi F; Bucciarelli P; Colombo M; Romeo R
    Thromb Res; 2007; 120(2):289-93. PubMed ID: 17049585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.
    Pötzsch B; Kawamura H; Preissner KT; Schmidt M; Seelig C; Müller-Berghaus G
    J Lab Clin Med; 1995 Jan; 125(1):56-65. PubMed ID: 7822946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Low sensibility to the action of thrombomodulin in cirrhotic patients. Interest of thrombinography].
    Sinegre T; Abergel A; Sapin AF; Lamblin G; Marques-Verdier A; Duron C; Lebreton A
    Ann Biol Clin (Paris); 2016; 74(2):203-12. PubMed ID: 26806287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects.
    De CR; Rocca B; Marchioli R; Landolfi R
    Thromb Haemost; 2002 Jan; 87(1):58-67. PubMed ID: 11848457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis.
    Cugno M; Scott CF; Salerno F; Lorenzano E; Müller-Esterl W; Agostoni A; Colman RW
    Thromb Haemost; 1999 Nov; 82(5):1428-32. PubMed ID: 10595632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.
    Tripodi A
    Thromb Haemost; 2017 May; 117(5):830-836. PubMed ID: 28229158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are total prostate-specific antigen serum levels in cirrhotic men different from those in normal men?
    Vicentini FC; Botelho LA; Hisano M; Ebaid GX; Lucon M; Lucon AM; Srougi M
    Urology; 2009 May; 73(5):1032-5. PubMed ID: 19286245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procoagulant versus anticoagulant factors in cirrhotic patients.
    El Bokl MA; Shawky A; Riad GS; Abdel Fattah HS; Shalaby H; Nady A; Khattab D
    Arab J Gastroenterol; 2014; 15(3-4):123-9. PubMed ID: 25249231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K; Svensson PJ; Ohlin AK
    Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombomodulin-modified thrombin generation testing detects a hypercoagulable state in patients with cirrhosis regardless of the exact experimental conditions.
    Groeneveld D; Porte RJ; Lisman T
    Thromb Res; 2014 Sep; 134(3):753-6. PubMed ID: 25065556
    [No Abstract]   [Full Text] [Related]  

  • 31. Uncoupling of sympathetic nervous system and hypothalamic-pituitary-adrenal axis in cirrhosis.
    Wiest R; Moleda L; Zietz B; Hellerbrand C; Schölmerich J; Straub R
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1901-8. PubMed ID: 18554237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass.
    Sniecinski R; Szlam F; Chen EP; Bader SO; Levy JH; Tanaka KA
    Anesth Analg; 2008 Mar; 106(3):713-8, table of contents. PubMed ID: 18292407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implication of inflammation-related cytokines in the natural history of liver cirrhosis.
    Girón-González JA; Martínez-Sierra C; Rodriguez-Ramos C; Macías MA; Rendón P; Díaz F; Fernández-Gutiérrez C; Martín-Herrera L
    Liver Int; 2004 Oct; 24(5):437-45. PubMed ID: 15482340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct-acting antivirals.
    Russo FP; Zanetto A; Campello E; Bulato C; Shalaby S; Spiezia L; Gavasso S; Franceschet E; Radu C; Senzolo M; Burra P; Lisman T; Simioni P
    Liver Int; 2018 Dec; 38(12):2210-2218. PubMed ID: 29738632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms.
    Joop K; Berckmans RJ; Nieuwland R; Berkhout J; Romijn FP; Hack CE; Sturk A
    Thromb Haemost; 2001 May; 85(5):810-20. PubMed ID: 11372673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired binding of thrombin to thrombomodulin is associated with risk of deep vein thrombosis.
    Suehisa E; Kawasaki T; Toku M; Hidaka Y
    Thromb Res; 2008; 123(1):85-92. PubMed ID: 18590927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adhesion molecules as a prognostic marker of liver cirrhosis.
    Girón-González JA; Martínez-Sierra C; Rodriguez-Ramos C; Rendón P; Macías MA; Fernández-Gutiérrez C; Díaz F; Martín-Herrera L
    Scand J Gastroenterol; 2005 Feb; 40(2):217-24. PubMed ID: 15764154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
    Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A
    J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombomodulin-modified thrombin generation after in vivo recombinant factor VIII treatment in severe hemophilia A.
    Dielis AW; Balliël WM; van Oerle R; Hermens WT; Spronk HM; Ten Cate H; Hamulyák K
    Haematologica; 2008 Sep; 93(9):1351-7. PubMed ID: 18641016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.